With U.S. healthcare spending projected to exceed $5.3 trillion in 2025, payers are under more pressure…
Category: News
Immune Repertoire Sequencing Market worth US$560.5 million by 2030 with 9.6% CAGR | MarketsandMarkets™
The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust…
Children’s Hospital of Philadelphia Researchers Find Gene Therapy Shows Long-Term Benefits for Hemophilia B Patients
Researchers at Children’s Hospital of Philadelphia (CHOP) in collaboration with researchers at Royal Prince Alfred Hospital in Sydney, Australia announced the results…
Lilly confirms date and conference call for first-quarter 2025 financial results announcement
Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2025 financial results on May 1, 2025. Lilly…
Crunch Franchisee CR Fitness Holdings Announces Newest Location in Grand Prairie, Texas
CR Fitness Holdings LLC., the fastest-growing and leading franchisee of Crunch Fitness, announced the upcoming opening…
InventHelp Inventors Develop New Cold Water Therapy Product (MJA-355)
Cold water therapy can offer a lot of health benefits, but standard methods can be expensive…
THE WELL AND TERRA LAUNCH THE WELL COCONUT GROVE: MIAMI’S ULTIMATE DESTINATION FOR HOLISTIC WELLNESS AND LUXURY LIVING
Terra, the leading South Florida developer, and THE WELL, internationally acclaimed wellness brand, proudly announce THE WELL Coconut Grove, a…
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Rigel Pharmaceuticals, Inc. (“Rigel”) (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel…
HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-A-Lago Club During the Week of January 6, 2025
HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) subsidiary, is inviting Qualified Institutional Investors to an…
AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call
AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2024 financial results on Friday, January 31, 2025, before…